Press Releases
  Date Title and Summary View
Sep 7, 2017
PDF
Aug 28, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 15th annual Morgan Stanley Global Healthcare Conference on Monday, September 11, 2017 at 11:40 am ET at the Grand Hyatt New ...
PDF
Aug 23, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Baird Global Healthcare Conference on Wednesday, September 6, 2017 at 10:50 am ET at the InterContinental New York Barclay. ...
PDF
Aug 3, 2017
GAAP and adjusted revenues of $547 million GAAP earnings per share from continuing operations of $0.57; Adjusted earnings per share of $0.67 GAAP operating margins expand by 150 basis points; Adjusted operating margins expand by 70 basis points ...
PDF
Aug 3, 2017
PerkinElmer Genetics Provides Complete Genomic Lab Testing Solution WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Genetics' clinical genomics services. Through...
PDF
Jul 24, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on July 24, 2017. This dividend is payable on November 10, 2017 to all shareholders of record at the close of business on October 20, 2017. ...
PDF
Jul 10, 2017
WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that on Thursday, August 3 2017, after market close, the Company will release second quarter 2017 results. The Company will also host a conference call the same d...
PDF
Jun 28, 2017
PDF
Jun 19, 2017
Accelerates revenue and earnings growth by adding leading positions in autoimmune and allergy diagnostics and strengthens leadership in China and other emerging markets Significant opportunity to leverage technologies, strong market positions and synergistic commercial activities to de...
PDF
May 4, 2017
GAAP revenue of $514 million, an increase of 3%; Organic revenue increased 4% GAAP earnings per share from continuing operations of $0.33; Adjusted earnings per share of $0.55 Raises full year revenue and earnings per share guidance ...
PDF
Page: FirstPrevious
2
... NextLast